A New Approach to Treating Brain Cancer: HDT Bio Launches Canadian Clinical Program at McGill University
HDT Bio Canada Inc. partners with McGill University and The Neuro to advance HDT-401, an investigational locally administered RNA immune...
Read moreDetails